<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19152683</PMID><DateCompleted><Year>2009</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2009</Year><Month>Jan</Month><Day>19</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak.</ArticleTitle><Pagination><StartPage>3</StartPage><MedlinePgn>3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1471-2334-9-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Human enterovirus 71 (HEV71) can cause Hand, foot, and mouth disease (HFMD) with neurological complications, which may rapidly progress to fulminant cardiorespiratory failure, and death. Early recognition of children at risk is the key to reduce acute mortality and morbidity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We examined data collected through a prospective clinical study of HFMD conducted between 2000 and 2006 that included 3 distinct outbreaks of HEV71 to identify risk factors associated with neurological involvement in children with HFMD.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Total duration of fever &gt;or= 3 days, peak temperature &gt;or= 38.5 degrees C and history of lethargy were identified as independent risk factors for neurological involvement (evident by CSF pleocytosis) in the analysis of 725 children admitted during the first phase of the study. When they were validated in the second phase of the study, two or more (&gt;or= 2) risk factors were present in 162 (65%) of 250 children with CSF pleocytosis compared with 56 (30%) of 186 children with no CSF pleocytosis (OR 4.27, 95% CI2.79-6.56, p &lt; 0.0001). The usefulness of the three risk factors in identifying children with CSF pleocytosis on hospital admission during the second phase of the study was also tested. Peak temperature &gt;or= 38.5 degrees C and history of lethargy had the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 28%(48/174), 89%(125/140), 76%(48/63) and 50%(125/251), respectively in predicting CSF pleocytosis in children that were seen within the first 2 days of febrile illness. For those presented on the 3rd or later day of febrile illness, the sensitivity, specificity, PPV and NPV of &gt;or= 2 risk factors predictive of CSF pleocytosis were 75%(57/76), 59%(27/46), 75%(57/76) and 59%(27/46), respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Three readily elicited clinical risk factors were identified to help detect children at risk of neurological involvement. These risk factors may serve as a guide to clinicians to decide the need for hospitalization and further investigation, including cerebrospinal fluid examination, and close monitoring for disease progression in children with HFMD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ooi</LastName><ForeName>Mong How</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Sibu Hospital, Sibu, Sarawak, Malaysia. monghow@pd.jaring.my.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>See Chang</ForeName><Initials>SC</Initials></Author><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Anand</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Podin</LastName><ForeName>Yuwana</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Perera</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Clear</LastName><ForeName>Daniella</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>del Sel</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Chieng</LastName><ForeName>Chae Hee</ForeName><Initials>CH</Initials></Author><Author ValidYN="Y"><LastName>Tio</LastName><ForeName>Phaik Hooi</ForeName><Initials>PH</Initials></Author><Author ValidYN="Y"><LastName>Cardosa</LastName><ForeName>Mary Jane</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Solomon</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G116/194</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002493" MajorTopicYN="N">Central Nervous System Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008296" MajorTopicYN="N" Type="Geographic">Malaysia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>1</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>1</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>2</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2009</Year><Month>1</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19152683</ArticleId><ArticleId IdType="pmc">PMC2637878</ArticleId><ArticleId IdType="doi">10.1186/1471-2334-9-3</ArticleId><ArticleId IdType="pii">1471-2334-9-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pallansch MA, Ross RP. In: Field's Virology. 4. Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editor. Vol. 1. Lippincott Williams &amp; Wilkins; 2001. Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses; pp. 723&#x2013;775.</Citation></Reference><Reference><Citation>Cardosa MJ, Krishnan S, Tio PH, Perera D, Wong SC. Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak. Lancet. 1999;354(9183):987&#x2013;991. doi: 10.1016/S0140-6736(98)11032-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(98)11032-2</ArticleId><ArticleId IdType="pubmed">10501361</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen E-R, Hsu K-H, Twu S-J, Chen K-T, Tsai S-F, Wang J-R, Shih S-R. An epidemic of enterovirus 71 infection in Taiwan. New England Journal of Medicine. 1999;341(13):929&#x2013;935. doi: 10.1056/NEJM199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan K, Goh K, Chong C, Teo E, Lau G, Ling A. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis. 2003;9:78&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2873753</ArticleId><ArticleId IdType="pubmed">12533285</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu H, Shimizu Y, Takeuchi Y, Ishiko H, Takada H. Outbreak of severe neurologic involvement associated with Enterovirus 71 infection. Pediatric Neurology. 1999;20(1):17&#x2013;23. doi: 10.1016/S0887-8994(98)00087-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0887-8994(98)00087-3</ArticleId><ArticleId IdType="pubmed">10029254</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S-M, Liu C-C, Tseng H-W, Wang J-R, Huang C-C, Chen Y-J, Yang Y-J, Lin S-J, Yeh T-F. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clinical Infectious Diseases. 1999;29(1):184&#x2013;190. doi: 10.1086/520149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/520149</ArticleId><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang F, Jan S, Chen P, Chi C, Wang T, Fu Y, Tsai C, Chang Y. Left ventricular dysfunction in children with fulminant enterovirus 71 infection: an evaluation of the clinical course. Clin Infect Dis. 2002;34(7):1020&#x2013;1024. doi: 10.1086/339445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/339445</ArticleId><ArticleId IdType="pubmed">11880970</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Lin T, Hsu K, Huang Y, Lin K, Hsueh C, Shih S, Ning H, Hwang M, Wang H. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999;354(9191):1682&#x2013;1686. doi: 10.1016/S0140-6736(99)04434-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(99)04434-7</ArticleId><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Podin Y, Akin W, del Sel S, Mohan A, Chieng CH, Perera D, Clear D, Wong D. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis. 2007;44(5):646&#x2013;656. doi: 10.1086/511073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/511073</ArticleId><ArticleId IdType="pubmed">17278054</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T-Y, Chang L-Y, Hsia S-H, Huang Y-C, Chiu C-H, Hsueh C, Shih S-R, Liu C-C, Wu M-H. The 1998 enterovirus 71 outbreak in Taiwan: Pathogenesis and management. Clinical Infectious Diseases. 2002;34(SUPPL 2)</Citation><ArticleIdList><ArticleId IdType="pubmed">11938497</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardosa M, Perera D, Brown B, Cheon D, Chan H, Chan K, Cho H, McMinn P. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis. 2003;9(4):461&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957976</ArticleId><ArticleId IdType="pubmed">12702227</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. Journal of Virology. 2001;75(16):7732&#x2013;7738. doi: 10.1128/JVI.75.16.7732-7738.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.16.7732-7738.2001</ArticleId><ArticleId IdType="pmc">PMC115010</ArticleId><ArticleId IdType="pubmed">11462047</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera D, Podin Y, Akin W, Tan C-S, Cardosa MJ. Incorrect identification of recent Asian strains of coxsackievirus A16 as human enterovirus 71: Improved primers for the specific detection of human enterovirus 71 by RT PCR. BMC Infectious Diseases. 2004;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC415548</ArticleId><ArticleId IdType="pubmed">15122971</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardosa MJ, Wang SM, Sum MSH, Tio PH. Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses. BMC Microbiol. 2002;2:9. doi: 10.1186/1471-2180-2-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-2-9</ArticleId><ArticleId IdType="pmc">PMC113253</ArticleId><ArticleId IdType="pubmed">12019028</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Solomon T, Podin Y, Mohan A, Akin W, Yusuf MA, del Sel S, Kontol KM, Lai BF, Clear D. Evaluation of Different Clinical Sample Types in Diagnosis of Human Enterovirus 71-Associated Hand-Foot-and-Mouth Disease. J Clin Microbiol. 2007;45(6):1858&#x2013;1866. doi: 10.1128/JCM.01394-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01394-06</ArticleId><ArticleId IdType="pmc">PMC1933032</ArticleId><ArticleId IdType="pubmed">17446325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M-T, Wang J-K, Lu FL, Wu E-T, Yeh S-J, Lee W-L, Wu J-M, Wu M-H. Heart rate variability monitoring in the detection of central nervous system complications in children with enterovirus infection. Journal of Critical Care. 2006;21(3):280&#x2013;286. doi: 10.1016/j.jcrc.2006.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2006.02.005</ArticleId><ArticleId IdType="pubmed">16990099</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J-N, Yao C-T, Yeh C-N, Huang C-C, Wang S-M, Liu C-C, Wu J-M. Critical management in patients with severe enterovirus 71 infection. Pediatrics International. 2006;48(3):250&#x2013;256. doi: 10.1111/j.1442-200X.2006.02198.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-200X.2006.02198.x</ArticleId><ArticleId IdType="pubmed">16732789</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L-Y, Hsia S-H, Wu C-T, Huang Y-C, Lin K-L, Fang T-Y, Lin T-Y. Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. Pediatric Infectious Disease Journal. 2004;23(4):327&#x2013;331. doi: 10.1097/00006454-200404000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-200404000-00010</ArticleId><ArticleId IdType="pubmed">15071287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Lei H, Huang M, Su L, Lin H, Yu C, Wang J, Liu C. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol. 2006;37(1):47&#x2013;52. doi: 10.1016/j.jcv.2006.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2006.05.009</ArticleId><ArticleId IdType="pubmed">16861032</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin TY, Huang YC, Tsao KC, Shih SR, Kuo ML, Ning HC, Chung PW, Kang CM. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. The Pediatric Infectious Disease Journal. 1999;18(12):1092&#x2013;1096. doi: 10.1097/00006454-199912000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-199912000-00013</ArticleId><ArticleId IdType="pubmed">10608631</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y-F, Chiu P-C, Chen C-C, Chen Y-Y, Hsieh K-S, Liu Y-C, Lai P-H, Chang H-W. Cardiac troponin I: A reliable marker and early myocardial involvement with meningoencephalitis after fatal enterovirus-71 infection. Journal of Infection. 2003;46(4):238&#x2013;243. doi: 10.1053/jinf.2002.1117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jinf.2002.1117</ArticleId><ArticleId IdType="pubmed">12799149</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong CY, Chan KP, Shah VA, Ng WYM, Lau G, Teo T-S, Lai SH, Ling AE. Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. Acta Paediatrica. 2003;92(10):1163&#x2013;1169. doi: 10.1080/08035250310005242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08035250310005242</ArticleId><ArticleId IdType="pubmed">14632332</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>